Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Small proline-rich protein 2E is a member of the small proline-rich protein (SPRR) family, clustered within the epidermal differentiation complex on chromosome 1q21[1][4]. SPRR2E is a cross-linked envelope protein expressed in keratinocytes, where it first appears in the cell cytosol and ultimately becomes cross-linked to plasma membrane proteins by transglutaminases to form the insoluble cornified envelope that underlies the cell membrane of terminally differentiated squamous epithelial cells[2][3][4]. This structure provides a critical permeability barrier for the skin, protecting against environmental insults and pathogens[1][2][4]. In addition, SPRR proteins, including SPRR2E, have been shown to have direct antimicrobial activity, contributing to cutaneous immune defense by disrupting bacterial membranes[6]. Dysregulated SPRR2E expression has been associated with skin barrier diseases such as psoriasis and ichthyosis vulgaris[1][4]. There is currently no evidence that SPRR2E is a direct therapeutic target for small molecules or biological drugs[3][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small proline-rich protein 2E (SPRR2E).